Skip to content

the evaluation of the efficacy and safety of Fermented garlic on improving liver function

A 12 week, multi-center, double blind, randomized, placebo-controlled clinical trial for the evaluation of the efficacy and safety of Fermented garlic on improving liver function

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0001181
Enrollment
68
Registered
2014-07-25
Start date
2014-07-17
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : To evaluate the efficacy of Fermented garlic intake on improving liver function over the 12 week course, study subjects are selected thorough screening are randomly assigned as tr

Sponsors

Bioland
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) older than 20 years and below 75 years 2) abnormal serum ?-GTP(gamma-glutamic transpeptidase) level and below 3-fold of normal range 3) individuals agreed to participate in the study voluntarily after sufficient explanation regarding the purpose and content of study

Exclusion criteria

Exclusion criteria: 1) alcoholism or drug addiction, heart disease, central nerve system(CNS) disorder 2) liver schirosis or hepatoma on ultrasonography 3) Aspartate aminotransferase(AST) or alanine Aminotransferase(ALT) > 3-fold of normal range 4) Alkaline Phosphatase(ALP) or lactate dehydrogenase(LDH) > 3-fold of normal range or Platelet 20 ng/mL 5) viral hepatitis 6) Hepatitis B surface antigen(HBs Ag) or antibodies to hepatitis C virus(HCV Ab) positive 7) Albumin = 3.5 g/dl or Total Bilirubin = 3 mg/dl

Design outcomes

Primary

MeasureTime frame
serum ?-GTP level

Secondary

MeasureTime frame
AST and ALT;AST/ALT ratio;Multidimentional Fatigue Scale (MFS) ;Total-cholesterol, Triglyceride, HDL-cholesterol,LDL-cholesterol

Countries

Korea, Republic of

Contacts

Public Contactsehong kim

The Catholic University of Korea, St. Vincent's Hospital

iron1600@naver.com

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026